ARTICLE | Company News
INNX, Advanced Biotherapy interferon gamma deal
May 5, 2004 7:00 AM UTC
Innogenetics (Euronext: INNX) and ADVB cross-licensed their respective interferon gamma IP related to various autoimmune diseases. The deal initially will cover rheumatoid arthritis (RA). The companie...